These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15715354)

  • 21. Paediatric Agranulocytosis Associated with Metamizole Treatment.
    Kılıç Ö; İşeri Nepesov M; Ulukapı HB; Özdemir ZC; Bör Ö; Dinleyici EÇ
    Paediatr Drugs; 2021 Jan; 23(1):105-110. PubMed ID: 33247375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective study of the incidence of agranulocytosis and aplastic anemia associated with the oral use of metamizole sodium in Poland.
    Maj S; Centkowski P
    Med Sci Monit; 2004 Sep; 10(9):PI93-5. PubMed ID: 15328493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutropenia, agranulocytosis and dipyrone.
    Hamerschlak N; Cavalcanti AB
    Sao Paulo Med J; 2005 Sep; 123(5):247-9. PubMed ID: 16358101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A possible increased risk of metamizole-associated neutropenia among COVID-19 patients.
    Lerman TT; Sagi M; Shafir Y; Sheena L; Cohen E; Goldberg E; Krause I
    Br J Clin Pharmacol; 2021 Jul; 87(7):2902-2906. PubMed ID: 33332642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NAT2 polymorphisms as a cause of metamizole-induced agranulocytosis.
    Radulovic I; Dogan B; Dohna-Schwake C; Schündeln MM; Siffert W; Möhlendick B
    Pharmacogenet Genomics; 2021 Aug; 31(6):140-143. PubMed ID: 33675325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Case Report - Metamizole-Induced Agranulocytosis].
    Gonnert FA; Meißner W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2018 May; 53(5):388-394. PubMed ID: 29772595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case-Control Surveillance Study.
    Huber M; Andersohn F; Sarganas G; Bronder E; Klimpel A; Thomae M; Konzen C; Kreutz R; Garbe E
    Eur J Clin Pharmacol; 2015 Feb; 71(2):219-27. PubMed ID: 25378038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case Report: Simultaneously Induced Neutropenia and Hemolysis After a Single Metamizole Dose.
    Allgaier R; Kandulski A; Gülow K; Maier L; Müller M; Tews HC
    Drugs R D; 2023 Jun; 23(2):93-98. PubMed ID: 36988798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990-2012.
    Stammschulte T; Ludwig WD; Mühlbauer B; Bronder E; Gundert-Remy U
    Eur J Clin Pharmacol; 2015 Sep; 71(9):1129-38. PubMed ID: 26169297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agranulocytosis attributed to metamizole: An analysis of spontaneous reports in EudraVigilance 1985-2017.
    Hoffmann F; Bantel C; Jobski K
    Basic Clin Pharmacol Toxicol; 2020 Feb; 126(2):116-125. PubMed ID: 31449718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fournier's gangrene after hemorrhoidectomy: association with drug-induced agranulocytosis. Report of a case.
    Cihan A; Menteş BB; Sucak G; Karamercan A; Naznedar R; Ferahköşe Z
    Dis Colon Rectum; 1999 Dec; 42(12):1644-8. PubMed ID: 10613488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The incidence of metamizole sodium-induced agranulocytosis in Poland.
    Maj S; Lis Y
    J Int Med Res; 2002; 30(5):488-95. PubMed ID: 12449518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metamizole (Dipyrone) as an Alternative Agent in Postoperative Analgesia in Patients with Contraindications for Nonsteroidal Anti-Inflammatory Drugs.
    Konijnenbelt-Peters J; van der Heijden C; Ekhart C; Bos J; Bruhn J; Kramers C
    Pain Pract; 2017 Mar; 17(3):402-408. PubMed ID: 27346584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Metamizol: current status in Dutch practice].
    van Diepen ATN; Simons P; Bos JM; Kramers C
    Ned Tijdschr Geneeskd; 2022 Jan; 166():. PubMed ID: 35138735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Early use and adequate dosage of G-csf in drug-induced agranulocytosis].
    Callao Molina V; Marso Alonso C; Macià Virgili J; Gómez Arbonés X
    Sangre (Barc); 1994 Aug; 39(4):297-8. PubMed ID: 7527159
    [No Abstract]   [Full Text] [Related]  

  • 36. Metamizole (dipyrone)-induced agranulocytosis: Does the risk vary according to ethnicity?
    Shah RR
    J Clin Pharm Ther; 2019 Feb; 44(1):129-133. PubMed ID: 30311250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Agranulocytosis after use of metamizole - an underestimated risk?].
    Schinz K; Waldfahrer F; Wüst W; Iro H
    Laryngorhinootologie; 2020 Oct; 99(10):707-712. PubMed ID: 32588405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fatal agranulocytosis after metamizole reexposure].
    Zeiner E; Blaser LS; Tisljar K; Heim D; Taegtmeyer A
    Praxis (Bern 1994); 2015 Jan; 104(3):151-4. PubMed ID: 25626384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tenoxicam-induced agranulocytosis, with good response to colony stimulating factor (G-CSF)].
    Sánchez Sevillano A; Blázquez Encinar JC; Femenia Pérez M; Mora Rufete MA
    An Med Interna; 1993 Oct; 10(10):519-20. PubMed ID: 7511003
    [No Abstract]   [Full Text] [Related]  

  • 40. Update on the incidence of metamizole sodium-induced blood dyscrasias in Poland.
    Basak GW; Drozd-Sokołowska J; Wiktor-Jedrzejczak W
    J Int Med Res; 2010; 38(4):1374-80. PubMed ID: 20926010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.